Logo image of OBLG

OBLONG INC (OBLG) Stock Fundamental Analysis

USA - NASDAQ:OBLG - US6744343038 - Common Stock

2.9 USD
-0.04 (-1.36%)
Last: 9/23/2025, 8:00:02 PM
Fundamental Rating

2

OBLG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 279 industry peers in the Software industry. No worries on liquidiy or solvency for OBLG as it has an excellent financial health rating, but there are worries on the profitability. OBLG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year OBLG has reported negative net income.
In the past year OBLG has reported a negative cash flow from operations.
OBLG had negative earnings in each of the past 5 years.
OBLG had a negative operating cash flow in each of the past 5 years.
OBLG Yearly Net Income VS EBIT VS OCF VS FCFOBLG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

OBLG has a worse Return On Assets (-93.58%) than 91.04% of its industry peers.
With a Return On Equity value of -108.65%, OBLG is not doing good in the industry: 78.14% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -93.58%
ROE -108.65%
ROIC N/A
ROA(3y)-237.61%
ROA(5y)-155.05%
ROE(3y)-345.63%
ROE(5y)-222.48%
ROIC(3y)N/A
ROIC(5y)N/A
OBLG Yearly ROA, ROE, ROICOBLG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

OBLG's Gross Margin of 29.34% is on the low side compared to the rest of the industry. OBLG is outperformed by 78.49% of its industry peers.
OBLG's Gross Margin has declined in the last couple of years.
OBLG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.56%
GM growth 5Y-19.85%
OBLG Yearly Profit, Operating, Gross MarginsOBLG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

7

2. Health

2.1 Basic Checks

OBLG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OBLG has been reduced compared to 1 year ago.
Compared to 5 years ago, OBLG has more shares outstanding
There is no outstanding debt for OBLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OBLG Yearly Shares OutstandingOBLG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
OBLG Yearly Total Debt VS Total AssetsOBLG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

OBLG has an Altman-Z score of -22.41. This is a bad value and indicates that OBLG is not financially healthy and even has some risk of bankruptcy.
OBLG has a Altman-Z score of -22.41. This is amonst the worse of the industry: OBLG underperforms 93.91% of its industry peers.
OBLG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -22.41
ROIC/WACCN/A
WACC11.37%
OBLG Yearly LT Debt VS Equity VS FCFOBLG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 7.21 indicates that OBLG has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.21, OBLG belongs to the top of the industry, outperforming 93.19% of the companies in the same industry.
A Quick Ratio of 7.21 indicates that OBLG has no problem at all paying its short term obligations.
OBLG has a better Quick ratio (7.21) than 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 7.21
Quick Ratio 7.21
OBLG Yearly Current Assets VS Current LiabilitesOBLG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

OBLG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -488.92%.
The Revenue for OBLG has decreased by -22.81% in the past year. This is quite bad
The Revenue for OBLG have been decreasing by -28.62% on average. This is quite bad
EPS 1Y (TTM)-488.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.16%
Revenue 1Y (TTM)-22.81%
Revenue growth 3Y-32.52%
Revenue growth 5Y-28.62%
Sales Q2Q%-3.11%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OBLG Yearly Revenue VS EstimatesOBLG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OBLG Yearly EPS VS EstimatesOBLG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 -200 -400 -600 -800 -1K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OBLG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OBLG Price Earnings VS Forward Price EarningsOBLG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OBLG Per share dataOBLG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OBLG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OBLONG INC

NASDAQ:OBLG (9/23/2025, 8:00:02 PM)

2.9

-0.04 (-1.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-05 2025-08-05
Earnings (Next)11-05 2025-11-05
Inst Owners1.8%
Inst Owner Change10.12%
Ins Owners12.42%
Ins Owner Change13.19%
Market Cap6.82M
Analysts82.86
Price TargetN/A
Short Float %2.28%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.89
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-13.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.77
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS1
BVpS4.79
TBVpS4.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -93.58%
ROE -108.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.34%
FCFM N/A
ROA(3y)-237.61%
ROA(5y)-155.05%
ROE(3y)-345.63%
ROE(5y)-222.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.56%
GM growth 5Y-19.85%
F-Score4
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.21
Quick Ratio 7.21
Altman-Z -22.41
F-Score4
WACC11.37%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-488.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.81%
Revenue growth 3Y-32.52%
Revenue growth 5Y-28.62%
Sales Q2Q%-3.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.17%
OCF growth 3YN/A
OCF growth 5YN/A